How to think about boosters in light of this week's Pfizer and Moderna news
Posted on AllSides January 27th, 2022
From The Left
Pfizer and BioNTech announced Tuesday that they're beginning a clinical trial for an Omicron-specific Covid-19 vaccine, and Moderna revealed Wednesday that it has entered Phase 2 of its own trial of a vaccine that targets the variant, which is by far the dominant one in the United States right now.
About 50% of eligible Americans have received a booster shot, according to the US Centers for Disease Control and Prevention, but the Pfizer and Moderna news might raise questions regardless. For those who have yet to get inoculated, should they wait until there is...
AllSides Media Bias Rating: Lean Left
